2025-04-08 18:23:19
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Mangalam Drugs and Organics Ltd Q4FY22 net profit climbs to Rs. 6.69 crores
Posted On : 2022-05-27 16:24:24( TIMEZONE : IST )
Mangalam Drugs And Organics Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 120.9555 crores during the period ended March 31, 2022 as compared to Rs. 101.88 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 6.6915 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 4.0222 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 4.23 for the period ended March 31, 2022 as compared to Rs. 2.54 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 120.9555 crs | ₹101.88 crs |  18.72% |
| Net Profit | ₹6.6915 crs | ₹4.0222 crs | 66.36% |
| EPS | ₹4.23 | ₹2.54 | 66.54% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 120.9555 crores during the period ended March 31, 2022 as compared to Rs.92.9008 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.6.6915 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.2.1542 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.4.23 for the period ended March 31, 2022 as compared to Rs.1.36 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 120.9555 crs | ₹92.9008 crs | 30.20% |
| Net Profit | ₹6.6915 crs | ₹2.1542 crs | 210.63% |
| EPS | ₹4.23 | ₹1.36 | 211.03% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.451.1578 crores during the Financial Year ended March 31, 2022 as compared to Rs.384.6978 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.19.6575 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.27.9709 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.12.42 for the Financial Year ended March 31, 2022 as compared to Rs.17.67 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹451.1578 crs | ₹384.6978 crs | 17.28% |
| Net Profit | ₹19.6575 crs | ₹27.9709 crs |  -29.72% |
| EPS | ₹12.42 | ₹17.67 | -29.71% |
Shares of Mangalam Drugs And Organics Limited was last trading in BSE at Rs. 111.55 as compared to the previous close of Rs. 108.70. The total number of shares traded during the day was 2824 in over 130 trades.
The stock hit an intraday high of Rs. 116.00 and intraday low of 109.70. The net turnover during the day was Rs. 322121.00.
